# Pharmacokinetics of Dactinomycin in Young Patients With Cancer

> **NCT00900354** · — · UNKNOWN · sponsor: **Children's Cancer and Leukaemia Group** · enrollment: 50 (estimated)

## Conditions studied

- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **GENETIC:** molecular genetic technique
- **OTHER:** mass spectrometry
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT00900354
- **Lead sponsor:** Children's Cancer and Leukaemia Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00900354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00900354, "Pharmacokinetics of Dactinomycin in Young Patients With Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00900354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*